Oncternal Therapeutics
Menu
About
Overview
Leadership
Back
Pipeline
Overview
ONCT-808
ONCT-534
Zilovertamab
Back
Science
Overview
Publications
Back
Investors
Overview
News Releases
Events & Presentations
Financial Reports
Stock Information
Analyst Coverage
Corporate Governance
Patients
Careers
Current Opportunities
Vision, Mission and Impact
Contact
Leadership Team
Executive Team
James Breitmeyer, MD, PhD
President and CEO
Richard Vincent
Chief Financial Officer
Salim Yazji, MD
Chief Medical Officer
Gunnar Kaufmann, PhD
Chief Scientific Officer
Rajesh Krishnan, PhD
Chief Technology Officer
Pablo Urbaneja
SVP Corporate Development
Chase Leavitt
General Counsel
Board of Directors
David F. Hale
Chairman
James Breitmeyer, MD, PhD
Director
Michael G. Carter, MD, ChB, FRCP
Director
Jill DeSimone
Director
Bill LaRue
Director
Xin Nakanishi, PhD
Director
Charles Theuer, MD, PhD
Director
Daniel Kisner, MD
Director
Robert J. Wills, PhD
Director
Rosemary Mazanet, MD, PhD
Director
Scientific Advisors
Jeffrey Toretsky, MD
Thomas Kipps, MD, PhD
Please ensure Javascript is enabled for purposes of
website accessibility